Epoetin alfa for the treatment of cancer- and chemotherapy-related anaemia: product review and update

Author： Henry David H  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.2, 2005-02, pp. : 295-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epoetin alfa improves QOL in cancer-related anaemia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 251, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Epoetin alfa improves QOL in cancer-related anaemia

By  

Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Darbepoetin Alfa: In Patients with Chemotherapy-Related Anaemia

By Cvetkovic R.S.   Goa K.L.  

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1067-1074

Adis International

Access to resources Recommend Favorite

Benefits Associated with an Early Hemoglobin Response to Epoetin Alfa Therapy in the Treatment of Chemotherapy-Related Anemia

By Campos Susana M.   Duh Mei Sheng   Lefebvre Patrick   Rosberg James  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 6, 2005-11 ,pp. : 807-816

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Epoetin alfa cost effective in chemotherapy-induced anaemia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite